相似文献
1
Leveraging APOBEC3 proteins to alter the HIV mutation rate and combat AIDS.
Future Virol. 2009 Nov 1;4(6):605. doi: 10.2217/fvl.09.59.
2
Variability in HIV-1 transmitted/founder virus susceptibility to combined APOBEC3F and APOBEC3G host restriction.
J Virol. 2025 Jan 31;99(1):e0160624. doi: 10.1128/jvi.01606-24. Epub 2024 Dec 23.
3
Simian Immunodeficiency Virus Vif and Human APOBEC3B Interactions Resemble Those between HIV-1 Vif and Human APOBEC3G.
J Virol. 2018 May 29;92(12). doi: 10.1128/JVI.00447-18. Print 2018 Jun 15.
4
Possible footprints of APOBEC3F and/or other APOBEC3 deaminases, but not APOBEC3G, on HIV-1 from patients with acute/early and chronic infections.
J Virol. 2014 Nov;88(21):12882-94. doi: 10.1128/JVI.01460-14. Epub 2014 Aug 27.
5
Mechanism of Enhanced HIV Restriction by Virion Coencapsidated Cytidine Deaminases APOBEC3F and APOBEC3G.
J Virol. 2017 Jan 18;91(3). doi: 10.1128/JVI.02230-16. Print 2017 Feb 1.
6
Stability of APOBEC3F in the Presence of the APOBEC3 Antagonist HIV-1 Vif Increases at the Expense of Co-Expressed APOBEC3H Haplotype I.
Viruses. 2023 Feb 7;15(2):463. doi: 10.3390/v15020463.
7
An Alu Element Insertion in Intron 1 Results in Aberrant Alternative Splicing of APOBEC3G Pre-mRNA in Northern Pig-Tailed Macaques () That May Reduce APOBEC3G-Mediated Hypermutation Pressure on HIV-1.
J Virol. 2020 Jan 31;94(4). doi: 10.1128/JVI.01722-19.
8
Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all.
J Mol Biol. 2014 Mar 20;426(6):1220-45. doi: 10.1016/j.jmb.2013.10.033. Epub 2013 Nov 2.
9
Endogenous origins of HIV-1 G-to-A hypermutation and restriction in the nonpermissive T cell line CEM2n.
PLoS Pathog. 2012;8(7):e1002800. doi: 10.1371/journal.ppat.1002800. Epub 2012 Jul 12.
10
Suppression of APOBEC3-mediated restriction of HIV-1 by Vif.
Front Microbiol. 2014 Aug 26;5:450. doi: 10.3389/fmicb.2014.00450. eCollection 2014.
引用本文的文献
1
CRISPR-Cas9 screen of E3 ubiquitin ligases identifies TRAF2 and UHRF1 as regulators of HIV latency in primary human T cells.
mBio. 2024 Apr 10;15(4):e0222223. doi: 10.1128/mbio.02222-23. Epub 2024 Feb 27.
2
Stochastic Modelling of HIV-1 Replication in a CD4 T Cell with an IFN Response.
Viruses. 2023 Jan 20;15(2):296. doi: 10.3390/v15020296.
3
Clinical Implications of APOBEC3-Mediated Mutagenesis in Breast Cancer.
Clin Cancer Res. 2023 May 1;29(9):1658-1669. doi: 10.1158/1078-0432.CCR-22-2861.
4
Human immunodeficiency virus-1 core: The Trojan horse in virus-host interaction.
Front Microbiol. 2022 Aug 29;13:1002476. doi: 10.3389/fmicb.2022.1002476. eCollection 2022.
5
Human TRIM5α: Autophagy Connects Cell-Intrinsic HIV-1 Restriction and Innate Immune Sensor Functioning.
Viruses. 2021 Feb 19;13(2):320. doi: 10.3390/v13020320.
6
Making Sense of Multifunctional Proteins: Human Immunodeficiency Virus Type 1 Accessory and Regulatory Proteins and Connections to Transcription.
Annu Rev Virol. 2017 Sep 29;4(1):241-260. doi: 10.1146/annurev-virology-101416-041654.
7
APOBEC3 Interference during Replication of Viral Genomes.
Viruses. 2015 Jun 11;7(6):2999-3018. doi: 10.3390/v7062757.
8
Suppression of APOBEC3-mediated restriction of HIV-1 by Vif.
Front Microbiol. 2014 Aug 26;5:450. doi: 10.3389/fmicb.2014.00450. eCollection 2014.
9
Host restriction of lentiviruses and viral countermeasures: APOBEC3 and Vif.
Viruses. 2013 Jul 30;5(8):1934-47. doi: 10.3390/v5081934.
10
The role of cytidine deaminases on innate immune responses against human viral infections.
Biomed Res Int. 2013;2013:683095. doi: 10.1155/2013/683095. Epub 2013 Jun 25.
本文引用的文献
1
Defining APOBEC3 expression patterns in human tissues and hematopoietic cell subsets.
J Virol. 2009 Sep;83(18):9474-85. doi: 10.1128/JVI.01089-09. Epub 2009 Jul 8.
2
A patch of positively charged amino acids surrounding the human immunodeficiency virus type 1 Vif SLVx4Yx9Y motif influences its interaction with APOBEC3G.
J Virol. 2009 Sep;83(17):8674-82. doi: 10.1128/JVI.00653-09. Epub 2009 Jun 17.
3
Identification of a novel WxSLVK motif in the N terminus of human immunodeficiency virus and simian immunodeficiency virus Vif that is critical for APOBEC3G and APOBEC3F neutralization.
J Virol. 2009 Sep;83(17):8544-52. doi: 10.1128/JVI.00651-09. Epub 2009 Jun 17.
4
Intracellular interactions between APOBEC3G, RNA, and HIV-1 Gag: APOBEC3G multimerization is dependent on its association with RNA.
Retrovirology. 2009 Jun 4;6:56. doi: 10.1186/1742-4690-6-56.
5
Tumultuous relationship between the human immunodeficiency virus type 1 viral infectivity factor (Vif) and the human APOBEC-3G and APOBEC-3F restriction factors.
Microbiol Mol Biol Rev. 2009 Jun;73(2):211-32. doi: 10.1128/MMBR.00040-08.
6
Likely role of APOBEC3G-mediated G-to-A mutations in HIV-1 evolution and drug resistance.
PLoS Pathog. 2009 Apr;5(4):e1000367. doi: 10.1371/journal.ppat.1000367. Epub 2009 Apr 3.
7
Optimal translation initiation enables Vif-deficient human immunodeficiency virus type 1 to escape restriction by APOBEC3G.
J Virol. 2009 Jun;83(11):5956-60. doi: 10.1128/JVI.00045-09. Epub 2009 Mar 18.
8
RNA-dependent oligomerization of APOBEC3G is required for restriction of HIV-1.
PLoS Pathog. 2009 Mar;5(3):e1000330. doi: 10.1371/journal.ppat.1000330. Epub 2009 Mar 6.
9
Enhanced replication and pathogenesis of Moloney murine leukemia virus in mice defective in the murine APOBEC3 gene.
Virology. 2009 Mar 15;385(2):455-63. doi: 10.1016/j.virol.2008.11.051. Epub 2009 Jan 15.
10
Distinct determinants in HIV-1 Vif and human APOBEC3 proteins are required for the suppression of diverse host anti-viral proteins.
PLoS One. 2008;3(12):e3963. doi: 10.1371/journal.pone.0003963. Epub 2008 Dec 17.
Zotero 插件